Hims(US:HIMS) ZACKS·2025-10-22 22:45Core Viewpoint - Hims & Hers Health, Inc. is experiencing a decline in stock price, with upcoming earnings expected to show significant year-over-year growth in both earnings and revenue [1][2][3]. Financial Performance - The company plans to announce its earnings on November 3, 2025, with analysts expecting earnings of $0.09 per share, representing a 50% year-over-year growth [2]. - The Zacks Consensus Estimate for revenue is projecting net sales of $583.68 million, up 45.35% from the previous year [2]. - Full-year estimates call for earnings of $0.59 per share and revenue of $2.35 billion, indicating year-over-year changes of +118.52% and +59.39%, respectively [3]. Analyst Estimates - Recent changes to analyst estimates reflect evolving short-term business trends, with positive revisions indicating a favorable outlook on the company's health and profitability [4]. - The consensus EPS projection has moved 1.63% lower in the past 30 days, and the company currently holds a Zacks Rank of 3 (Hold) [6]. Valuation Metrics - Hims & Hers Health, Inc. has a Forward P/E ratio of 83.89, which is a premium compared to the industry average Forward P/E of 41.13 [7]. - The company's PEG ratio is currently 3.42, compared to the Medical Info Systems industry's average PEG ratio of 3.34 [7]. Industry Context - The Medical Info Systems industry, part of the Medical sector, has a Zacks Industry Rank of 88, placing it within the top 36% of over 250 industries [8]. - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [8].